scholarly journals Multiple binding modes of ibuprofen in human serum albumin identified by absolute binding free energy calculations

2016 ◽  
Author(s):  
Stefania Evoli ◽  
David L. Mobley ◽  
Rita Guzzi ◽  
Bruno Rizzuti

AbstractHuman serum albumin possesses multiple binding sites and transports a wide range of ligands that include the anti-inflammatory drug ibuprofen. A complete map of the binding sites of ibuprofen in albumin is difficult to obtain in traditional experiments, because of the structural adaptability of this protein in accommodating small ligands. In this work, we provide a set of predictions covering the geometry, affinity of binding and protonation state for the pharmaceutically most active form (S– isomer) of ibuprofen to albumin, by using absolute binding free energy calculations in combination with classical molecular dynamics (MD) simulations and molecular docking. The most favorable binding modes correctly reproduce several experimentally identified binding locations, which include the two Sudlow’s drug sites (DS2 and DS1) and the fatty acid binding sites 6 and 2 (FA6 and FA2). Previously unknown details of the binding conformations were revealed for some of them, and formerly undetected binding modes were found in other protein sites. The calculated binding affinities exhibit trends which seem to agree with the available experimental data, and drastically degrade when the ligand is modeled in a protonated (neutral) state, indicating that ibuprofen associates with albumin preferentially in its charged form. These findings provide a detailed description of the binding of ibuprofen, help to explain a wide range of results reported in the literature in the last decades, and demonstrate the possibility of using simulation methods to predict ligand binding to albumin.Graphical abstractFocusAlchemical free energy methods can identify favored binding modes of a ligand within a large protein with multiple binding sitesHighlightsHuman serum albumin binds the anti-inflammatory drug ibuprofen in multiple sitesAlchemical free energy calculations predicted favored binding modes of ibuprofenBound geometry, affinity and protonation state of the ligand were determinedSimulations identified a number of previously undetected binding sites for ibuprofenFree energy methods can be used to study large proteins with multiple binding sites

2016 ◽  
Vol 18 (47) ◽  
pp. 32358-32368 ◽  
Author(s):  
Stefania Evoli ◽  
David L. Mobley ◽  
Rita Guzzi ◽  
Bruno Rizzuti

Alchemical free energy methods can identify favored binding modes of a ligand within a large protein with multiple binding sites.


Talanta ◽  
2004 ◽  
Vol 63 (2) ◽  
pp. 503-508 ◽  
Author(s):  
C. André ◽  
Y.C. Guillaume

1986 ◽  
Vol 154 (3) ◽  
pp. 545-552 ◽  
Author(s):  
Anders Overgaard PEDERSEN ◽  
Birthe HUST ◽  
Signe ANDERSEN ◽  
Frede NIELSEN ◽  
Rolf BRODERSEN

2012 ◽  
Vol 18 (1) ◽  
pp. 9-17 ◽  
Author(s):  
Orsolya Dömötör ◽  
Christian G. Hartinger ◽  
Anna K. Bytzek ◽  
Tamás Kiss ◽  
Bernhard K. Keppler ◽  
...  

2013 ◽  
Vol 104 (2) ◽  
pp. 430a ◽  
Author(s):  
Eileen S. Krenzel ◽  
Heidi A. Schwanz ◽  
Ravi Jasu ◽  
Michael Zakharov ◽  
Shalendar Bhasin ◽  
...  

2020 ◽  
Vol 21 (16) ◽  
pp. 5740
Author(s):  
Hrvoje Rimac ◽  
Tana Tandarić ◽  
Robert Vianello ◽  
Mirza Bojić

Human serum albumin (HSA) is the most abundant carrier protein in the human body. Competition for the same binding site between different ligands can lead to an increased active concentration or a faster elimination of one or both ligands. Indomethacin and quercetin both bind to the binding site located in the IIA subdomain. To determine the nature of the HSA-indomethacin-quercetin interactions, spectrofluorometric, docking, molecular dynamics studies, and quantum chemical calculations were performed. The results show that the indomethacin and quercetin binding sites do not overlap. Moreover, the presence of quercetin does not influence the binding constant and position of indomethacin in the pocket. However, binding of quercetin is much more favorable in the presence of indomethacin, with its position and interactions with HSA significantly changed. These results provide a new insight into drug-drug interactions, which can be important in situations when displacement from HSA or other proteins is undesirable or even desirable. This principle could also be used to deliberately prolong or shorten the xenobiotics’ half-life in the body, depending on the desired outcomes.


2019 ◽  
Vol 17 (1) ◽  
pp. 806-812
Author(s):  
Liangliang Liu ◽  
Yi Liu ◽  
Aiping Xiao ◽  
Shiyong Mei ◽  
Yixi Xie

AbstractIncreasing the degree of glycation in diabetes could affect the ability of plasma proteins in binding to small molecules and active compounds. In this study, the influence of glycation of Human serum albumin (HSA) on the binding affinities for six dietary flavonoids was investigated by fluorescence spectra. Glycated HSA was prepared through incubation with glucose and characterized by several methods to confirm the glycation. It was found that the level of glycation increased with the increasing incubation time. The glycation of HSA increased the binding affinities for flavonoids by 1.40 to 48.42 times, which indicates that modifications caused by the glycation may have different influences on the interactions of flavonoids with HSA at separate binding sites on this protein. These results are valuable for understanding the influence of diabetes on the metabolism of flavonoids and other bioactive small molecules in human body.


Sign in / Sign up

Export Citation Format

Share Document